On this interview with Andrew Kleuss on Traders Hub, Vitaliy makes the case that issues over Amazon’s access into the prescription drugs trade are almost certainly overblown. To parse this drawback, Vitaliy differentiates between pharmacies and drug vendors, and analyzes the level to which Amazon can compete with each. Whilst Amazon may position some power on pharmacies over the years, he explains how drug vendors’ distinctive provide chains will have to stay tough in opposition to a aggressive risk from Amazon.
The submit Amazon Pharmacy vs The Marketplace & Vendors – Ep 105 gave the impression first on The Highbrow Investor.
